Evidence map›Paper›PMID 25301185›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2014

P2Y2 purinergic receptor activation is essential for efficient hepatocyte proliferation in response to partial hepatectomy.

Bryan C Tackett, Hongdan Sun, Yu Mei, Janielle P Maynard, Sayuri Cheruvu, Arunmani Mani, Andres Hernandez-Garcia, Nadarajah Vigneswaran, Saul J Karpen, Sundararajah Thevananther

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Purinergic Receptor P2Y2 Activity Prevents DNA Damage in CClJournal of cellular biochemistry · 2025
    Article
  4. Review
  5. The P2YPurinergic signalling · 2024
    Article
  6. Purinergic Signaling in Non-Parenchymal Liver Cells.International journal of molecular sciences · 2024
    Review
  7. Article
  8. Therapeutic potential for P2YPurinergic signalling · 2023
    Review
  9. Review
  10. Review
  11. Article
  12. Receptor-specific CaiScience · 2021
    Article
  13. Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension.International journal of environmental research and public health · 2021
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Purinergic signaling in hepatic disease.Purinergic signalling · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Bryan C TackettDepartment of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Texas Children's Liver Center, Houston, Texas; Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas;
Hongdan SunDepartment of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Texas Children's Liver Center, Houston, Texas;
Yu MeiDepartment of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Texas Children's Liver Center, Houston, Texas;
Janielle P MaynardDepartment of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Texas Children's Liver Center, Houston, Texas; Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas;
Sayuri CheruvuDepartment of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Texas Children's Liver Center, Houston, Texas;
Arunmani ManiDepartment of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Texas Children's Liver Center, Houston, Texas;
Andres Hernandez-GarciaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas; and.
Nadarajah VigneswaranDepartment of Diagnostic Sciences, University of Texas Dental Branch in Houston, Houston, Texas.
Saul J KarpenDepartment of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Texas Children's Liver Center, Houston, Texas; Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas;
Sundararajah ThevanantherDepartment of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Texas Children's Liver Center, Houston, Texas; Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas; sundarat@bcm.edu.
Texas Children's Hospital · USBaylor College of Medicine · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3M
Research Training in Pediatrics GastroenterolgyT32DK007664 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI DOUGLAS G BURRIN · 1991 to 2026
$8.4M
Training Program in Translational Biology and Molecular MedicineT32GM088129 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI ROONEY, CLIONA M., VAN DEN VEYVER, IGNATIA B · 2010 to 2019
$3.0M
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cellsR01DE024392 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ANNAPRAGADA, ANANTH V, VIGNESWARAN, NADARAJAH · 2014 to 2017
$1.5M
Purinergic Regulation of hepatocyte proliferationR01DK069558 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI THEVANANTHER, SUNDARARAJAH · 2006 to 2010
$1.3M
NIDCR NIH HHS R01 DE024392NIDDK NIH HHS DK56338NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R01 DK069558NIDDK NIH HHS T32 DK007664NIDDK NIH HHS T32 DK07644NIGMS NIH HHS T32 GM088129NIGMS NIH HHS T32 GM88129
6 · The paper itself

Abstract

Extracellular nucleotides via activation of P2 purinergic receptors influence hepatocyte proliferation and liver regeneration in response to 70% partial hepatectomy (PH). Adult hepatocytes express multiple P2Y (G protein-coupled) and P2X (ligand-gated ion channels) purinergic receptor subtypes. However, the identity of key receptor subtype(s) important for efficient hepatocyte proliferation in regenerating livers remains unknown. To evaluate the impact of P2Y2 purinergic receptor-mediated signaling on hepatocyte proliferation in regenerating livers, wild-type (WT) and P2Y2 purinergic receptor knockout (P2Y2-/-) mice were subjected to 70% PH. Liver tissues were analyzed for activation of early events critical for hepatocyte priming and subsequent cell cycle progression. Our findings suggest that early activation of p42/44 ERK MAPK (5 min), early growth response-1 (Egr-1) and activator protein-1 (AP-1) DNA-binding activity (30 min), and subsequent hepatocyte proliferation (24-72 h) in response to 70% PH were impaired in P2Y2-/- mice. Interestingly, early induction of cytokines (TNF-α, IL-6) and cytokine-mediated signaling (NF-κB, STAT-3) were intact in P2Y2-/- remnant livers, uncovering the importance of cytokine-independent and nucleotide-dependent early priming events critical for subsequent hepatocyte proliferation in regenerating livers. Hepatocytes isolated from the WT and P2Y2-/- mice were treated with ATP or ATPγS for 5-120 min and 12-24 h. Extracellular ATP alone, via activation of P2Y2 purinergic receptors, was sufficient to induce ERK phosphorylation, Egr-1 protein expression, and key cyclins and cell cycle progression of hepatocytes in vitro. Collectively, these findings highlight the functional significance of P2Y2 purinergic receptor activation for efficient hepatocyte priming and proliferation in response to PH.

Indexed as

HepatectomyAdenosine TriphosphateAnimalsCell CycleCell ProliferationCyclinsEarly Growth Response Protein 1HepatocytesMaleMAP Kinase Signaling SystemMiceMice, Inbred C57BLMice, KnockoutPurinergic P2Y Receptor AgonistsReceptors, Purinergic P2Y2adenosine 5'-O-(3-thiotriphosphate)Adenosine TriphosphateCyclinsEarly Growth Response Protein 1Egr1 protein, mousePurinergic P2Y Receptor AgonistsReceptors, Purinergic P2Y2extracellular ATPhepatocyte proliferationliver regenerationP2Y2 purinergic receptorspartial hepatectomy

Identifiers

PMID25301185
PMCPMC4254960
OpenAlexW2321101625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.